Snowden Capital Advisors LLC Atri Cure, Inc. Transaction History

Snowden Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $1,946 - $2,606	69 Added 0.79%	8,758 $266,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $46,153 - $60,506	1,399 Added 19.19%	8,689 $310,000
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $5,098 - $7,158	-124 Reduced 1.67%	7,290 $319,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $566 - $694	14 Added 0.19%	7,414 $365,000
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $8,967 - $11,805	250 Added 3.5%	7,400 $306,000
Q4 2022 Feb 13, 2023	BUY	$33.48 - $47.45 $18,447 - $26,144	551 Added 8.35%	7,150 $317,000
Q3 2022 Nov 09, 2022	BUY	$38.25 - $52.62 $252,411 - $347,239	6,599 New	6,599 $258,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.4B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.